PRESS RELEASE published on 05/03/2023 at 12:30, 2 years 11 months ago Empower Clinics Advances Research and Clinical Trials Division with The Signing of Another Experienced Principal Investigator
PRESS RELEASE published on 04/25/2023 at 12:30, 2 years 11 months ago Empower Clinics Accelerates Growth of Research and Clinical Trials Division with Signing of Two Additional Principal Investigators at First Site in Dallas, Texas
PRESS RELEASE published on 04/20/2023 at 12:30, 2 years 11 months ago Empower Clinics Announces Official Launch of Mobile Technology & Communications Platform, PulseIR Powered by Fobi
PRESS RELEASE published on 04/17/2023 at 12:30, 2 years 11 months ago Empower Clinics Signs Agreement To Conduct Research and Clinical Trials with Dallas, TX Based Medical Center - And Major Milestone With Signing Of Research Services Agreement With First Principal Investigator
PRESS RELEASE published on 03/21/2023 at 11:00, 3 years ago Empower Clinics Announces Exploration of Strategic Alternatives
PRESS RELEASE published on 03/20/2023 at 08:00, 3 years ago Empower Clinics Cancels Previously Announced Private Placement
PRESS RELEASE published on 03/07/2023 at 13:00, 3 years 1 month ago Empower Clinics Advances Partnership to Launch US Clinical Trial Management Services with Formation of Delaware Based Company and Identification of Principal Investigators
PRESS RELEASE published on 03/01/2023 at 01:20, 3 years 1 month ago CORRECTION: Empower Clinics Reports Q4 2022 Results
PRESS RELEASE published on 02/28/2023 at 23:00, 3 years 1 month ago Empower Clinics Reports Q4 2022 Results
PRESS RELEASE published on 02/27/2023 at 23:40, 3 years 1 month ago CORRECTION: Empower Clinics Announces FOBI Partnership To Elevate Investor Relations With Digital, Mobile and Personalized Engagement
Published on 04/17/2026 at 02:13, 1 hour 10 minutes ago CHAR Tech annonce l’acquisition projetée d’actifs de biocarbone au Québec, incluant un accord d’achat de 62 500 tonnes, une installation et de la propriété intellectuelle
Published on 04/17/2026 at 02:00, 1 hour 23 minutes ago UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement
Published on 04/16/2026 at 23:32, 3 hours 51 minutes ago Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/16/2026 at 21:30, 5 hours 53 minutes ago Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 23:40, 3 hours 43 minutes ago Coventry Ranks #1 in 2025 Life Settlement League Table Report
Published on 04/16/2026 at 21:37, 5 hours 46 minutes ago Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 6 hours 23 minutes ago Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 6 hours 48 minutes ago EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 8 hours 5 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:02, 9 hours 21 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 17:54, 9 hours 29 minutes ago Aéroports de Paris S.A - March 2026 traffic figures
